NHS
NICE recommends Pfizer’s rimegepant for preventing episodic migraine attacks
June 2, 2023Medical Communications NHS, NICE, Neurology, Pfizer, migraine
The National Institute for Health and Care Excellence (NICE) has announced that it has recommended an oral treatment for the …
NHS given guidance on offering genetic testing to stroke patients
May 19, 2023Medical Communications NHS, Neurology, blood clot, genetic testing, stroke
The NHS has been given draft guidance on offering gene tests to patients who have had a stroke caused by …
NICE recommends Hepcludex for NHS use to treat aggressive form of viral hepatitis
May 15, 2023Medical Communications NHS, NICE, Virology, hepatitis
The National Institute for Health and Care Excellence (NICE) has recommended Hepcludex (bulevirtide) for the treatment of chronic hepatitis delta …
NHS in Scotland makes rheumatoid arthritis drug available
September 14, 2021Manufacturing and Production Galapagos UK, NHS, Scotland, filgotinib, rheumatoid arthritis
The Scottish Medicines Consortium (SMC) have recommended the use of Galapagos UK’s JYSELECA® (filgotinib) for eligible patients with severe active …
Long COVID: 15 studies launched with £19.6 million government funding
July 19, 2021Sales and Marketing NHS, UK, long covid
The UK government has announced the launch of 15 new extensive studies, backed by £19.6 million in funding, to investigate …
‘It’s Time for Trodelvy’: Charity launches petition against Gilead for drug access
July 19, 2021Sales and Marketing Cancer, Gilead, NHS, charity
The charity Breast Cancer Now has launched a petition calling on Gilead to provide free-of-charge access to its new treatment …
Fears for pregnant women as COVID restrictions ease
July 15, 2021COVID-19, NHS, Vaccine, maternity
The Royal College of Obstetricians and Gynaecologists (RCOG) and the Royal College of Midwives (RCM) have expressed fears over the …
Lethal triple mix of winter viruses could “push NHS to breaking point”
July 15, 2021COVID-19, NHS, influenza
A report from the Academy of Medical Sciences has found that a lethal triple mix of COVID-19, influenza, and the …
NICE recommends that all women should do pelvic floor exercises
June 29, 2021Manufacturing and Production NHS, NICE, pelvic floor, women's health
NICE has recommended in draft guidance that girls as young as 12 should be encouraged to do pelvic floor muscle …
Tapeworm drug to be trialled nationally as COVID treatment
June 25, 2021Medical Communications COVID-19, NHS, dialysis, kindey, tapeworm
Kidney patients in Bristol are being offered a clinical trial to see whether a drug used for tapeworm patients can …
UK AI firm wins share of £140 million funding for lung cancer detection tech
June 18, 2021Medical Communications AI, CT, NHS, funding, lunch cancer, screening, technology
Artificial intelligence firm Behold.ai has won a share of £140 million in government funding for its red dot lung cancer …
NHS to pilot artificial pancreas for type 1 diabetes
June 17, 2021NHS, diabetes, insulin, technology, wearable technology
The NHS has announced that artificial pancreases will be available to patients with type 1 diabetes, with up to 1,000 …
Lucida Medical gains CE marking for AI prostate cancer tech
June 1, 2021Manufacturing and Production AI, MRI, NHS, prostate cancer
Cambridge-based AI company, Lucida Medical, has received CE marking for its new machine learning-based prostate cancer detection software, Prostate Intelligence …
Abbvie psoriatic arthritis drug approved for use in Scotland
May 11, 2021Manufacturing and Production AbbVie, NHS, arthritis, psoriatic arthritis
Abbvie’s RINVOQ (upadacitinib) drug, for the treatment of active psoriatic arthritis (PsA) in adults, has been approved for use in …
NICE rejects Merck Serono’s Bavencio for urothelial cancer
May 10, 2021Sales and Marketing MSD, Merck, NHS, NICE, cancer treatment, pharma, pharma news
The use of avelumab for maintenance treatment of locally advanced or metastatic urothelial cancer after platinum-based chemotherapy is not recommended by …
